{"id":962016,"date":"2026-05-13T07:12:52","date_gmt":"2026-05-13T11:12:52","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-present-at-the-rbc-capital-markets-2026-global-healthcare-conference\/"},"modified":"2026-05-13T07:12:52","modified_gmt":"2026-05-13T11:12:52","slug":"opus-genetics-to-present-at-the-rbc-capital-markets-2026-global-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-present-at-the-rbc-capital-markets-2026-global-healthcare-conference\/","title":{"rendered":"Opus Genetics to Present at the RBC Capital Markets 2026 Global Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">RESEARCH TRIANGLE PARK, N.C., May  13, 2026  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=BjRZs4UTJSkdG1wO4-a8ageY3mzNXHuQk1FtuxwxTPA9UrWqHowwqLF76c-nv6doDaXbr0MhJZw-PrZh6R_gpgcLUNK5iTZbjmGcKnFSsdw=\" rel=\"nofollow\" target=\"_blank\">Opus Genetics, Inc.<\/a> (Nasdaq: IRD) (\u201cOpus Genetics\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases (IRDs), announced today that management will present at the RBC Capital Markets 2026 Global Healthcare Conference on Tuesday, May 19, 2026 at 11:00 a.m. ET.<\/p>\n<p align=\"left\">A link to the live and archived webcast may be accessed on Opus Genetics\u2019 website under the Investors section: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tAOiDJjmFhBXcEe_kbhhdvtQUTQ43lw1l5GMtFdYApIn5QEReBnBCIqPHDHuqGO-AmjVG-2xl6JLUE1XfazXpA==\" rel=\"nofollow\" target=\"_blank\">Events<\/a>.<\/p>\n<p align=\"left\">\n        <strong>About Opus Genetics<\/strong>\n      <\/p>\n<p align=\"left\">Opus Genetics is a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases (IRDs). The Company is developing durable, one-time treatments designed to address the underlying genetic causes of severe retinal disorders. The Company\u2019s pipeline includes seven AAV-based programs, led by OPGx-LCA5 for LCA5-related mutations and OPGx-BEST1 for BEST1-related retinal degeneration, with additional candidates targeting RDH12, MERTK, RHO, CNGB1 and NMNAT1. The Company is based in Research Triangle Park, NC. For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8zD6gThktYYijS_QO8mMrQVO1X7m2AFMQTuVn7rA6B93_gDmaP5UgwePHNewqkbgblQ17ZXc6T7CTf8GzNfXBCOyeiQciA9i_m5vy_wF0ZjxFreOgmwVdd8IDWAjfFboRqSlDPB9Bw4hh0le8OTS-oIs8WC3qw2ZiNrYd0LViqv9UMixQ5uFkvGE4mzQoq6UpNfD-RXUaQV0oVpHJuVfWIMyFLktsZNIB0nEtFl_tcc=\" rel=\"nofollow\" target=\"_blank\">www.opusgtx.com<\/a>.<\/p>\n<p align=\"left\">\n        <strong>Contacts:<\/strong>\n      <\/p>\n<p align=\"left\">\n        <strong>Investors<\/strong><br \/>\n        <br \/>Jenny Kobin<br \/>Remy Bernarda<br \/>IR Advisory Solutions<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dpXdORy57fWj9iPdICrg2Y_KucTOvSUeAa4VQ9Q-OMdxq7X0TdkLsnsZgmWAmkn7JCjVOuaGund-sP2RC7vm5Q==\" rel=\"nofollow\" target=\"_blank\">ir@opusgtx.com<\/a><\/p>\n<p align=\"left\">\n        <strong>Media<\/strong><br \/>\n        <br \/>Kimberly Ha<br \/>KKH Advisors<br \/>917-291-5744<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uRn_XKlHjRzY6QvCzCUrlDdd1Ogu_FO5YsDsj_ib2VyNhvNMNj4F0JdkZtS57qTpnCrqCZC_jcvI7y4S1O7ZhakOnc2Z0W_xLujIeFhhxifF9fkSN7nL7tGfRwUehhvI\" rel=\"nofollow\" target=\"_blank\">kimberly.ha@kkhadvisors.com<\/a><\/p>\n<p align=\"left\">Source: Opus Genetics, Inc.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxODQ2NSM3NTk4MzI0IzIzMDE3NjA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MmMxYWU5YTctOWRkNS00YTM1LThlMGItODY3ODVkMDYwM2U2LTEzMTMzMTAtMjAyNi0wNS0xMy1lbg==\/tiny\/Opus-Genetics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>RESEARCH TRIANGLE PARK, N.C., May 13, 2026 (GLOBE NEWSWIRE) &#8212; Opus Genetics, Inc. (Nasdaq: IRD) (\u201cOpus Genetics\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases (IRDs), announced today that management will present at the RBC Capital Markets 2026 Global Healthcare Conference on Tuesday, May 19, 2026 at 11:00 a.m. ET. A link to the live and archived webcast may be accessed on Opus Genetics\u2019 website under the Investors section: Events. About Opus Genetics Opus Genetics is a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases (IRDs). The Company is developing durable, one-time treatments designed to address &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-present-at-the-rbc-capital-markets-2026-global-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Opus Genetics to Present at the RBC Capital Markets 2026 Global Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-962016","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Opus Genetics to Present at the RBC Capital Markets 2026 Global Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-present-at-the-rbc-capital-markets-2026-global-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Opus Genetics to Present at the RBC Capital Markets 2026 Global Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"RESEARCH TRIANGLE PARK, N.C., May 13, 2026 (GLOBE NEWSWIRE) &#8212; Opus Genetics, Inc. (Nasdaq: IRD) (\u201cOpus Genetics\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases (IRDs), announced today that management will present at the RBC Capital Markets 2026 Global Healthcare Conference on Tuesday, May 19, 2026 at 11:00 a.m. ET. A link to the live and archived webcast may be accessed on Opus Genetics\u2019 website under the Investors section: Events. About Opus Genetics Opus Genetics is a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases (IRDs). The Company is developing durable, one-time treatments designed to address &hellip; Continue reading &quot;Opus Genetics to Present at the RBC Capital Markets 2026 Global Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-present-at-the-rbc-capital-markets-2026-global-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-13T11:12:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxODQ2NSM3NTk4MzI0IzIzMDE3NjA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opus-genetics-to-present-at-the-rbc-capital-markets-2026-global-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opus-genetics-to-present-at-the-rbc-capital-markets-2026-global-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Opus Genetics to Present at the RBC Capital Markets 2026 Global Healthcare Conference\",\"datePublished\":\"2026-05-13T11:12:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opus-genetics-to-present-at-the-rbc-capital-markets-2026-global-healthcare-conference\\\/\"},\"wordCount\":208,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opus-genetics-to-present-at-the-rbc-capital-markets-2026-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxODQ2NSM3NTk4MzI0IzIzMDE3NjA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opus-genetics-to-present-at-the-rbc-capital-markets-2026-global-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opus-genetics-to-present-at-the-rbc-capital-markets-2026-global-healthcare-conference\\\/\",\"name\":\"Opus Genetics to Present at the RBC Capital Markets 2026 Global Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opus-genetics-to-present-at-the-rbc-capital-markets-2026-global-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opus-genetics-to-present-at-the-rbc-capital-markets-2026-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxODQ2NSM3NTk4MzI0IzIzMDE3NjA=\",\"datePublished\":\"2026-05-13T11:12:52+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opus-genetics-to-present-at-the-rbc-capital-markets-2026-global-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opus-genetics-to-present-at-the-rbc-capital-markets-2026-global-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opus-genetics-to-present-at-the-rbc-capital-markets-2026-global-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxODQ2NSM3NTk4MzI0IzIzMDE3NjA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxODQ2NSM3NTk4MzI0IzIzMDE3NjA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opus-genetics-to-present-at-the-rbc-capital-markets-2026-global-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Opus Genetics to Present at the RBC Capital Markets 2026 Global Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Opus Genetics to Present at the RBC Capital Markets 2026 Global Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-present-at-the-rbc-capital-markets-2026-global-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Opus Genetics to Present at the RBC Capital Markets 2026 Global Healthcare Conference - Market Newsdesk","og_description":"RESEARCH TRIANGLE PARK, N.C., May 13, 2026 (GLOBE NEWSWIRE) &#8212; Opus Genetics, Inc. (Nasdaq: IRD) (\u201cOpus Genetics\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases (IRDs), announced today that management will present at the RBC Capital Markets 2026 Global Healthcare Conference on Tuesday, May 19, 2026 at 11:00 a.m. ET. A link to the live and archived webcast may be accessed on Opus Genetics\u2019 website under the Investors section: Events. About Opus Genetics Opus Genetics is a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases (IRDs). The Company is developing durable, one-time treatments designed to address &hellip; Continue reading \"Opus Genetics to Present at the RBC Capital Markets 2026 Global Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-present-at-the-rbc-capital-markets-2026-global-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2026-05-13T11:12:52+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxODQ2NSM3NTk4MzI0IzIzMDE3NjA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-present-at-the-rbc-capital-markets-2026-global-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-present-at-the-rbc-capital-markets-2026-global-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Opus Genetics to Present at the RBC Capital Markets 2026 Global Healthcare Conference","datePublished":"2026-05-13T11:12:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-present-at-the-rbc-capital-markets-2026-global-healthcare-conference\/"},"wordCount":208,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-present-at-the-rbc-capital-markets-2026-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxODQ2NSM3NTk4MzI0IzIzMDE3NjA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-present-at-the-rbc-capital-markets-2026-global-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-present-at-the-rbc-capital-markets-2026-global-healthcare-conference\/","name":"Opus Genetics to Present at the RBC Capital Markets 2026 Global Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-present-at-the-rbc-capital-markets-2026-global-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-present-at-the-rbc-capital-markets-2026-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxODQ2NSM3NTk4MzI0IzIzMDE3NjA=","datePublished":"2026-05-13T11:12:52+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-present-at-the-rbc-capital-markets-2026-global-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-present-at-the-rbc-capital-markets-2026-global-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-present-at-the-rbc-capital-markets-2026-global-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxODQ2NSM3NTk4MzI0IzIzMDE3NjA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxODQ2NSM3NTk4MzI0IzIzMDE3NjA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-present-at-the-rbc-capital-markets-2026-global-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Opus Genetics to Present at the RBC Capital Markets 2026 Global Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/962016","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=962016"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/962016\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=962016"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=962016"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=962016"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}